Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Christine M. Kleinert Institute for Hand and Microsurgery Jewish Hospital and St. Mary's Healthcare Kleinert, Kutz and Associates University of Louisville U.S. Army Medical Research and Materiel Command Department of Defense |
---|---|
Information provided by: | Christine M. Kleinert Institute for Hand and Microsurgery |
ClinicalTrials.gov Identifier: | NCT00711373 |
This is a clinical trial of hand transplantation. This will be done by the surgical transfer of a hand from a non-living donor to restore function of non-functioning or amputated hand. Recipients must currently take the same type of drugs as a kidney transplant patient to prevent rejection of the hand.
Condition | Intervention | Phase |
---|---|---|
Upper Extremity Injuries Amputation |
Procedure: Allogeneic hand transplantation |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | Composite Tissue Allotransplantation of the Hand |
Estimated Enrollment: | 10 |
Study Start Date: | June 1998 |
Estimated Study Completion Date: | June 2011 |
Estimated Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
At the Christine M. Kleinert Institute in Louisville, Kentucky, we are recruiting patients for a research protocol that is underway for Composite Tissue Allotransplantation of the Hand. This study is not for all upper extremity injuries, but it is a possibility for some.
The Hand Surgeons at Kleinert, Kutz and Associates have performed the only three hand transplants in the US out of a total of 38 that have been performed worldwide. All three of our patients are doing well. For more information visit www.handtransplant.com.
While hand transplantation is a viable option for select upper extremity amputees, there are significant risks that must be understood before a patient can decide whether hand transplantation is the right option for him or her. The major risk is the systemic immunosuppression that all current hand transplant recipients must take.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Warren C Breidenbach, MD | 502-561-4286 | wbreidenbach@kleinertkutz.com |
Contact: Brenda Blair, RN | 502-562-0313 | bblair@cmki.org |
United States, Kentucky | |
Kleinert Kutz and Associates/Jewish Hospital and St. Mary's Healthcare | Recruiting |
Louisville, Kentucky, United States, 40202 | |
Contact: Warren C Breidenbach, MD 502-561-4286 wbreidenbach@kleinertkutz.com | |
Contact: Brenda Blair, RN 502-562-0313 bblair@cmki.org | |
Principal Investigator: Warren C Breidenbach, MD |
Principal Investigator: | Warren C Breidenbach, MD | Kleinert, Kutz and Associates |
Responsible Party: | Kleinert, Kutz and Associates ( Warren C. Breidenbach ) |
Study ID Numbers: | 192.98, DoD-OAR A-14022.5 |
Study First Received: | July 7, 2008 |
Last Updated: | July 9, 2008 |
ClinicalTrials.gov Identifier: | NCT00711373 History of Changes |
Health Authority: | United States: Institutional Review Board |
CTA composite tissue allotransplantation amputation Hand |
Wounds and Injuries Disorders of Environmental Origin Arm Injuries |
Wounds and Injuries Disorders of Environmental Origin Arm Injuries |